Division Of Renal Diseases And Hypertension is categorized under Medical Research in Denver, CO and active since 1997.
Division Of Renal Diseases And Hypertension was established in 1997, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Thomas Berle at the company’s single location by writing to 4200 East 9th Avenue C281, Denver, Colorado CO 80220 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Division Of Renal Diseases And Hypertension |
| Contact Person: | Thomas Berle |
| Address: | 4200 East 9th Avenue C281, Denver, Colorado 80220 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Division Of Renal Diseases And Hypertension was started in 1997 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Thomas Berle for inquiries that concern Division Of Renal Diseases And Hypertension by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Division Of Renal Diseases And Hypertension can be found at the coordinates as well as the street address 4200 East 9th Avenue C281 in Denver, Colorado 80220.
For its online presence, you may visit Division Of Renal Diseases And Hypertension’s website at and engage with its social media outlets through on Twitter and on Facebook.